| Views | |
|---|---|
| ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion | 64 |
| August 2024 | September 2024 | October 2024 | November 2024 | December 2024 | January 2025 | February 2025 | |
|---|---|---|---|---|---|---|---|
| ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion | 1 | 0 | 1 | 0 | 1 | 2 | 0 |
| Views | |
|---|---|
| EMBR_EMBR202154305.pdf | 91 |
